Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea

키워드

참고문헌 (40)

1. Sang Soo Lee, "Type and cause of liver disease in Korea: single-center experience, 2005-2010", Clinical and Molecular Hepatology, 18(3), pp.309~315 (2012), 대한간학회[DOI]
2. Kim BH, "Populationbased prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea", PLoS ONE, 12, pp.e0182391~ (2017)[DOI]
3. European Association for the Study of the Liver, "EASL clinical practice guidelines: Autoimmune hepatitis", J Hepatol, 63, pp.971~1004 (2015)[DOI]
4. Manns MP, "Diagnosis and management of autoimmune hepatitis", Hepatology, 51, pp.2193~2213 (2010)[DOI]
5. Lim YS, "Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule", J Hepatol, 48, pp.133~139 (2008)[DOI]
6. Lee JH, "Current state of autoimmune hepatitis in Korea", Clin Mol Hepatol, 10(Suppl 5), pp.S21~S30 (2004)
7. Kim BH, "Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study", J Gastroenterol Hepatol, 28, pp.128~134 (2013)[DOI]
8. 길재숙, "Long-term Treatment Outcomes for Autoimmune Hepatitis in Korea", Journal of Korean Medical Science, 25(1), pp.54~60 (2010), 대한의학회
9. Alvarez F, "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis", J Hepatol, 31, pp.929~938 (1999)[DOI]
10. Hennes EM, "Simplified criteria for the diagnosis of autoimmune hepatitis", Hepatology, 48, pp.169~176 (2008)[DOI]
11. Onji M, "Autoimmune hepatitis: Diagnosis and treatment guide in Japan, 2013", Hepatol Res, 44, pp.368~370 (2014)[DOI]
12. Adams LA, "The prevalence of autoantibodies and atoimmune hepatitis in patients with nonalcoholic fatty liver disease", Am J Gastroenterol, 99, pp.1316~1320 (2004)[DOI]
13. Yatsuji S, "Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?", J Gastroenterol, 40, pp.1130~1138 (2005)[DOI]
14. 조대현, "비알코올성 지방간질환이 의심되는 환자에서 자가항체의 발현 빈도와 임상적 의의에 관한 전향적 연구", Clinical and Molecular Hepatology, 11(2005), pp.261~267 (2005), 대한간학회
15. Muller P, "Non-alcoholic fatty liver disease potentiates autoimmune hepatitis in the CYP2D6 mouse model", J Autoimmunity, 69, pp.51~58 (2016)[DOI]
16. Aizawa Y, "Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis", Eur J Gastroenterol Hepatol, 28, pp.391~397 (2016)
17. Nguyen Canh H, "Acute presentation of autoimmune hepatitis: a multicenter study with detailed histological evaluation in a large cohort of patients", J Clin Pathol, 70, pp.961~969 (2017)[DOI]
18. Manns MP, "Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis", Gastroenterology, 139, pp.1198~1206 (2010)[DOI]
19. Chinese Society of Hepatology, "Chinese consensus on the diagnosis and management of autoimmune hepatitis (2015)", J Dig Dis, 18, pp.247~264 (2017)[DOI]
20. Hoeroldt B, "Longterm outcomes of patients with autoimmune hepatitis managed at a nontransplant center", Gastroenterology, 140, pp.1980~1989 (2011)[DOI]
21. Gronbaek L, "Autoimmune hepatitis in Denmark: Incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study", J Hepatol, 60, pp.612~617 (2014)[DOI]
22. Tansel A, "Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 15, pp.1207~1217 (2017)[DOI]
23. Cho CW, "Comparative analysis of the clinical outcomes of liver transplantation for probable and definite autoimmune hepatitis by international diagnostic scoring criteria", Transplant Proc, 49, pp.1126~1128 (2017)[DOI]
24. Cho JM, "De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution’s experience", Transplant Proc, 43, pp.2394~2396 (2011)[DOI]
25. Kim KA, "Populationbased epidemiology of primary biliary cirrhosis in South Korea", Aliment Pharmacol Ther, 43, pp.154~162 (2016)[DOI]
26. Griffiths L, "The new epidemiology of primary biliary cirrhosis", Semin Liver Dis, 34, pp.318~328 (2014)[DOI]
27. Joshita S, "Genetic contribution to the pathogenesis of primary biliary cholangitis", J Immunol Res, 2017, pp.3073504~ (2017)
28. 김경아, "한국인 원발성 담즙성 간경변증의 임상 특징 및 예후", Clinical and Molecular Hepatology, 16(2), pp.139~146 (2010), 대한간학회
29. 박윤상, "Retrospective analysis of autoimmune hepatitis–primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes", Clinical and Molecular Hepatology, 21(2), pp.150~157 (2015), 대한간학회
30. Han E, "Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis", Clin Chim Acta, 464, pp.113~117 (2017)[DOI]
31. European association for the study of the Liver, "EASL clinical practice guidelines: The diagnosis and management of patients with primary biliary cholangitis", J Hepatol, 67, pp.145~172 (2017)[DOI]
32. Chen S, "A brief review on prognostic models of primary biliary cholangitis", Hepatol Int, 11, pp.412~418 (2017)[DOI]
33. Lammers WJ, "Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy", Gastrotenterology, 149, pp.1804~1812 (2015)[DOI]
34. Hosonuma K, "A prospective randomized controlled study of longterm combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia", Am J Gastroenterol, 110, pp.423~431 (2015)[DOI]
35. Nevens F, "A placebo-controlled trial of obeticholic acid in primary biliary cholangitis", N Engl J Med, 375, pp.631~643 (2016)[DOI]
36. Hegade VS, "Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a doubleblind, randomized placebo-controlled, crossover, phase 2a study", Lancet, 389, pp.1114~1123 (2017)[DOI]
37. Harada K, "Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: National data from Japan", Hepatology, 57, pp.1942~1949 (2013)[DOI]
38. Trivedi PJ, "Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis; a multicenter international study", Gut, 65, pp.321~329 (2016)[DOI]
39. Carbone M, "Autoimmune liver disease, autoimmunity and liver transplantation", J Hepatol, 60, pp.210~223 (2014)[DOI]
40. Egawa H, "Longterm outcomes of living-donor liver transplantation for primary biliary cirrhosis: A Japanese multicenter study", Am J Transplnat, 16, pp.1248~1257 (2016)[DOI]

관련 논문AI추천